Description
8,00,000 equity shares of Vanta Bioscience Limited issued at Rs. 50/- to promoters on preferential basis listed on BSE with effect from October 17, 2025.
Summary
Vanta Bioscience Limited (Scrip Code: 540729) has listed 8,00,000 new equity shares on BSE effective October 17, 2025. These shares were issued to promoters on a preferential basis at Rs. 50/- per share (face value Rs. 10/- plus premium of Rs. 40/-) and are subject to lock-in until April 29, 2027.
Key Points
- 8,00,000 equity shares of Rs. 10/- each issued at premium of Rs. 40/-
- Issue price: Rs. 50/- per share
- Allotment to promoters on preferential basis
- Date of allotment: May 6, 2025
- Trading commences: October 17, 2025
- Shares ranking pari-passu with existing equity shares
- ISIN: INE695X01011
- Distinctive Numbers: 6312001 to 7112000
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Trading members are informed about the listing of new securities and lock-in restrictions. The entire 8,00,000 shares are subject to lock-in provisions and cannot be transferred until April 29, 2027.
Important Dates
- Allotment Date: May 6, 2025
- Listing Date: October 17, 2025
- Lock-in Period Ends: April 29, 2027
- Notice Date: October 16, 2025
Impact Assessment
This is a routine listing of preferential shares issued to promoters. The impact on market operations is minimal as the shares are locked-in for approximately 18 months. The preferential issue strengthens the promoter holding and provides capital to the company. No immediate trading impact expected due to lock-in restrictions.
Impact Justification
Routine listing of preferential shares to promoters with standard lock-in provisions, minimal market impact